Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease

Chinese Medical Journal

Volumn 123, Issue 14, 2010, Pages 1845-1851

  An, Li ^a   Lin, Ying Xiang ^a   Yang, Ting ^a   Zhang, Hong ^a   Jiao, Xia ^a   Zhang, Shu ^a   Chang, Xiao Hong ^a   Wang, Zhao Mei ^a   Wang, Chen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anxiety; BODE index; Chronic obstructive pulmonary disease; Depression; Stable

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ANXIETY DISORDER; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSTRUMENT VALIDATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PREDICTIVE VALIDITY; PROSPECTIVE STUDY; QUALITY OF LIFE; WALKING SPEED;

ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; HUMANS; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 78649570822     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.14.004     Document Type: Article

References (33)

1. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. (Accessed July 10, 2007 at http://www.goldcopd.org)
2. Celli BR, MacNee W. Standards for the diagnosis and treatment of COPD. Eur Respir J 2004; 23: 932-946.
3. Hay JG, Stone P, Carter J, Church S, Eyre-Brook A, Pearson MG, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992; 5: 659-664.
4. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
5. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 102-108.
6. Wouters EFM, Schols AMWJ. Prevalence and pathophysiology of nutritional depletion in chronic obstructive pulmonary disease. Respir Med 1993; 87 Suppl B: 45-47.
7. Schols AM, Soeters P, Dingemans M, Mostert R, Frantzen P, Wouters E. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151-1156.
8. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD): a review. Nord J Psychiatry 2004; 58: 65-70.
9. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2006; 12:113-117.
10. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67.
11. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008; 178: 913-920.
12. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003, 84: 1154-1157.
13. Paz-Diaz H, Montes de OM, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2007; 86: 30-36.
14. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100: 115-122.
15. Ekberg-Aronsson M, Pehrsson K, Nilssson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98.
16. Kerstjens HA. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med 2004; 170: 212-213.
17. Medinas-Amorós M, Alorda C, Renom F, Rubí M, Centeno J, Ferrer V, et al. Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity of the BODE index. Chron Respir Dis 2008; 5: 7-11.
18. Ong KC, Lu SJ, Soh CS. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis 2006; 1: 91-96.
19. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study. Respir Res 2009; 10: 1.
20. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
21. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
22. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52: 69-77.
23. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
24. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 384-404.
25. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
26. American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
28. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128: 3810-3816.
29. Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with chronic obstructive pulmonary disease. Chest 2007; 132: 148-155.
30. Celli BR, Snider GL, Heffner J. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152 (5 Pt 2): S77-S121.
31. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005; 26: 630-636.
32. Bailey PH. The dyspnea-anxiety-dyspnea cycle - COPD patients' stories of breathlessness: ''It's scary/When you can't breathe''. Qual Health Res 2004; 14: 760-778.
33. Cooper CB. Determining the role of exercise in patients with chronic pulmonary disease. Med Sci Sports Exerc 1995; 27: 147-157.